<span>Rhodophytes or Red Algae is the phylum of algae that stores food in the form of floridean starch. It is one of the most established gatherings of eukaryotic green growth. The Rhodophyta likewise includes one of the biggest phyla of green growth, containing more than 7,000 as of now perceived species with ordered corrections continuous.</span>
Sexual reproduction produces offsprings that resemble their parents but are at the same time unique genetically.
Answer: D - Eukaryotic
Explanation: Can not be A, B or C
- Prokaryotic cells can not make up multicellular organisms
- Bacterial cells are prokaryotes and unicellular
- Not all multicellular organisms are plants and are therefore not all made of plant cells
Answer: D.) a suggested answer to a problem
Explanation:
A hypothesis is a supposition, suggested answer or a proposed explanation based on limited evidence which can be use to start an investigation. A hypothesis is more than a guess but less than a established theory and it can be tested through study and experiments.
<u>A hypothesis is part of the scientific method </u>because it is a prediction which can be tested and the results from those experiments may disprove a hypothesis, but can never entirely prove one.
It is not a conclusion because it is an idea which tries to explain an observation. It is not information collected from experiments because hypothesis are formulated before carrying out the experiments and it is not a widely accepted idea because it just proposes a tentative explanation about a phenomenon.
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
